MedTech Dive September 30, 2024
Investors are waiting to learn the next steps for the patient monitoring company after a hard-fought proxy battle, including how a separation of its consumer business could play out.
Masimo’s leadership transition brings a two-year boardroom feud to a close, but questions remain about the path forward in the wake of CEO Joe Kiani’s exit.
Kiani resigned after losing his board seat in a Sept. 19 shareholder vote, ending his tenure 35 years after founding the pulse oximetry firm. The former CEO also filed a lawsuit in California related to his employment agreement. BTIG analysts wrote in a recent investor note that they “expect this legal effort to be important in determining whether Mr. Kiani receives a sizable special payment.”
...Today's Sponsors
Today's Sponsor